These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 474034)

  • 1. Study on the reproducibility of human prolactin response to sulpiride, benserazide, insulin hypoglycaemia and arginine infusion.
    Pontiroli AE; Gala RR; Pellicciotta G; De Pasqua A; Girardi AM; Pozza G
    Acta Endocrinol (Copenh); 1979 Jul; 91(3):410-20. PubMed ID: 474034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benserazide and nomifensine in the diagnosis of prolactin-secreting pituitary adenomas.
    Pontiroli AE; Loda G; Roggia A; Scagliola P; Falsetti L
    Acta Endocrinol (Copenh); 1982 Oct; 101(2):171-9. PubMed ID: 7136447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of normal aging on the prolactin response to graded doses of sulpiride and to arginine.
    Nair NP; Lal S; Thavundayil JX; Isaac I; Eugenio H; Achim A; Schwartz G; Guyda H
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):633-7. PubMed ID: 4089188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benserazide effects on growth hormone, prolactin, and thyrotropin in normal and acromegalic man.
    Masturzo P; De Maria A; Murialdo G; Bonura ML; Zauli C; Polleri A
    J Clin Endocrinol Metab; 1985 Aug; 61(2):378-81. PubMed ID: 4008612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms involved in the prolactin-releasing effect of benserazide.
    Parati EA; Penalva A; Bondiolotti GP; Parenti M; Locatelli V; Picotti GB; Cocchi D; Müller EE
    Eur J Pharmacol; 1984 Jun; 101(3-4):215-21. PubMed ID: 6468496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolactin responsiveness to repeated decremental doses of sulpiride.
    Tormey WP; Buckley MP; Taaffe W; O'Kelly DA; Darragh A
    Horm Metab Res; 1981 Aug; 13(8):454-5. PubMed ID: 7327523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence of impaired PRL responses to sulpiride in patients with PRL secreting pituitary adenomas after successful hypophysectomy.
    Hanew K; Sasaki A; Sato S; Kasai M; Murata K; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1983 Jul; 140(3):225-33. PubMed ID: 6414103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulpiride on plasma prolactin levels in women with puerperal or pathological hyperprolactinaemia.
    Massara F; Camanni F; Belforte L; Campagnoli C; Novi RF; Molinatti GM
    Acta Endocrinol (Copenh); 1980 Oct; 95(2):145-50. PubMed ID: 7435113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolactin unresponsiveness to repeated sulpiride administration in man: recent findings.
    Bernini GP; Gasperi M; Gravina G; Vivaldi MS; Del Corso C; Santoni R; Luisi M; Franchi F
    J Endocrinol Invest; 1987 Apr; 10(2):131-5. PubMed ID: 3108355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary hormone secretion after inhibition of L-aromatic amino acid decarboxylase activity in man.
    Delitala G; Devilla L; Pende A
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):438-43. PubMed ID: 7456974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The autonomy of prolactin secretion in patients with prolactin producing tumor.
    Hanew K; Sasaki A; Sato S; Murata K; Fukui M; Koh K; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1982 May; 137(1):101-7. PubMed ID: 6808703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benserazide induces migraine attacks. Irrelevance of concomitant hyperprolactinemia.
    Polleri A; Murialdo G; Martignoni E; Nappi G; Savoldi F
    Farmaco Sci; 1979 May; 34(5):465-8. PubMed ID: 554794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 1-5 hydroxytryptophan infusion on growth hormone and prolactin secretion in man.
    Lancranjan I; Wirz-Justice A; Pühringer W; Del Pozo E
    J Clin Endocrinol Metab; 1977 Sep; 45(3):588-93. PubMed ID: 302840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic evaluation of prolactin secretion with sulpiride and thyrotrophin releasing hormone in amenorrhoeic and normally menstruating women.
    D'Agata R; Aliffi A; Gulizia S; Vicari E
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):311-4. PubMed ID: 6789593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benserazide, a stimulator of prolactin release: a new test in the diagnosis of pituitary prolactin-secreting tumours.
    Pontiroli AE; Falsetti L; Voltolini AM; Alberetto M; Pellicciotta G; de Pasqua A; Girardi AM; Pozza G
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):326-32. PubMed ID: 7293664
    [No Abstract]   [Full Text] [Related]  

  • 16. Postreceptorial refractoriness of prolactin release mechanisms.
    Collu R; Ducharme JR; Eljarmak D; Marchisio AM; Bertrand J; Sabbagh I; Guillaumot P; Cohen H
    Can J Physiol Pharmacol; 1983 Jul; 61(7):676-84. PubMed ID: 6616329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unresponsiveness of prolactin to repeated injection of sulpiride in man.
    Cohen H; Pugeat M; Tourniaire J; Bertrand J
    Eur J Clin Pharmacol; 1983; 25(2):275-7. PubMed ID: 6628512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxone inhibits sulpiride-induced hyperprolactinaemia in man.
    Bernini GP; Pedrinelli R; Salvetti A; Franchi F; Luisi M
    Eur J Clin Invest; 1985 Oct; 15(5):272-5. PubMed ID: 3935458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulating action of sulpiride and pimozide on prolactin release. Effect on bromocriptine, L-dopa and metergoline administration.
    Delitala G
    Acta Endocrinol (Copenh); 1977 Oct; 86(2):251-6. PubMed ID: 578618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The stimulation of prolactin secretion by sulpiride in "adolescent gynaecomastia".
    D'Agata R; Andó S; Gulizia S; Condorelli L; Paci C; Scapagnine U; Polosa P
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):692-7. PubMed ID: 578053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.